Patent · US Active

Imidazo[1,2-a]pyridine compounds

US8497278B2 · kind B2 · utility

0Cited by

5References

10Claims

0Family size

Assignee

Sunovion Pharmaceuticals Inc. · US

Inventors

Qun Kevin Fang · Wellesley, US
Frank Xinhe Wu · Shrewsbury, US
Paul Grover · Marlborough, US
Seth Cabot Hopkins · Northborough, US
Una Campbell · Marlborough, US
Milan Chytil · Clinton, US
Kerry L. Spear · Oakland, US

Key dates

Filing date	May 19, 2009
Grant date	Jul 30, 2013
Priority date	—
Expiry date	May 31, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Imidazo[1,2-a]pyridines are disclosed. Compounds of the invention are useful therapeutic agents and their inclusion in pharmaceutical formulations and use in methods of treatment are disclosed. Many of the compounds disclosed herein may be represented by the following generic formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.